Prescription bottles are containers used for dispensing pharmaceutical drugs in measured doses to patients on prescription. They help organize medications, prevent accidental ingestions, and protect drugs from contamination. The rising prevalence of chronic diseases and growing geriatric population has increased the demand for prescription drugs globally, fueling the need for prescription bottles.

The global Prescription Bottles Market is estimated to be valued at US$ 4.56 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends: Increased demand for prescription medicine

One of the key trends driving the prescription bottles market is the increased demand for prescription medicine. The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer etc. has significantly increased the consumption of prescription drugs globally. As prescription bottles are used to dispense prescription drugs, the rising demand for prescription medication is expected to translate into increased demand for prescription bottles over the forecast period. According to estimations, chronic diseases affect over 100 million Americans and are the leading cause of death and disability in the US. This growing burden of chronic diseases has augmented the sales as well as production of prescription drugs, thereby fueling the need for prescription bottles.

Segment Analysis

The global prescription bottles market is dominated by plastic prescription bottles segment due to its widespread use. Plastic prescription bottles are lightweight, durable and are cost effective compared to glass bottles. This makes plastic prescription bottles the preferred choice for prescription packaging.

Key Takeaways

The Global Prescription Bottles Market Share is expected to witness high growth during the forecast period of 2023 to 2030. With a CAGR of 5.4%, the market size is projected to reach US$ 7.24 Bn by 2030 from US$ 4.56 Bn in 2023.

Regional analysis: North America currently dominates the global prescription bottles market attributed to rising healthcare expenditure and developed healthcare infrastructure in the region. Within North America, the US holds the largest share due to presence of major players and increasing cases of chronic diseases leading to rise in pharmaceutical sales. Asia Pacific is expected to be the fastest growing region during the forecast period supported by growing aging population, increasing healthcare awareness and rising penetration of health insurance in developing countries of Asia Pacific region such as India and China.

Key players: Key players operating in the prescription bottles market are Kibion AB, Avanos Medical, Inc., Quest Diagnostics, Beijing Richen-Force Science & Technology Co., Ltd., Paladin Labs Inc., Beijing Binal Health Bio- Sci & Tech Co., Ltd., AB ANALITICA s.r.l., Otsuka Holdings Co., Ltd., Sercon Group, Campro Scientific GmbH, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., Avisa Diagnostics, INFAI GmbH, Meridian Bioscience, Inc., Metabolic Solutions, Inc., Laboratory Corporation of America Holdings, Gulf Coast Scientific, Inc., FAN GmbH, and Kizlon Medical.

For more insights, Read- http://marketerefforts.weebly.com/home/prescription-bottles-market-is-estimated-to-witness-high-growth-owing-to-opportunity-for-increasing-medicine-adherence